XML 13 R2.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Consolidated Statements of Income (Loss) (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Income Statement [Abstract]        
Net sales $ 309,664 $ 295,268 $ 916,156 $ 903,284
Cost of sales 108,233 106,454 318,584 360,675
Product remediation 1,642 689 2,573 2,243
Gross profit 199,789 188,125 594,999 540,366
Operating expenses:        
Selling, general and administrative 121,177 109,233 353,943 345,744
Research and development 31,393 32,175 104,051 94,076
Merger and integration expenses 2,013 7,576 7,743 20,537
Restructuring expenses 792 4,381 12,060 37,219
Amortization of intangibles 12,350 11,775 35,445 33,959
Total operating expenses 167,725 165,140 513,242 531,535
Income from operations 32,064 22,985 81,757 8,831
Interest income 199 585 724 1,119
Interest expense (1,421) (3,495) (5,314) (6,665)
Gain on acquisition of Caisson Interventional, LLC 0 0 39,428 0
Foreign exchange and other gains (losses) 491 1,216 957 (2)
Income before income taxes 31,333 21,291 117,552 3,283
Income tax expense 1,913 9,731 10,881 16,891
Losses from equity method investments (1,590) (13,129) (20,072) (19,382)
Net income (loss) $ 27,830 $ (1,569) $ 86,599 $ (32,990)
Basic income (loss) per share (in Dollars per Share) $ 0.58 $ (0.03) $ 1.80 $ (0.67)
Diluted income (loss) per share (in Dollars per Share) $ 0.57 $ (0.03) $ 1.79 $ (0.67)
Shares used in computing basic income (loss) per share (in Shares) 48,181 49,075 48,130 49,016
Shares used in computing diluted income (loss) per share (in Shares) 48,534 49,075 48,339 49,016